JP2023052094A5 - - Google Patents

Download PDF

Info

Publication number
JP2023052094A5
JP2023052094A5 JP2022209142A JP2022209142A JP2023052094A5 JP 2023052094 A5 JP2023052094 A5 JP 2023052094A5 JP 2022209142 A JP2022209142 A JP 2022209142A JP 2022209142 A JP2022209142 A JP 2022209142A JP 2023052094 A5 JP2023052094 A5 JP 2023052094A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
cycloalkyl
compound according
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022209142A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023052094A (ja
JP7617890B2 (ja
Filing date
Publication date
Priority claimed from JP2021555178A external-priority patent/JP7204005B2/ja
Application filed filed Critical
Publication of JP2023052094A publication Critical patent/JP2023052094A/ja
Publication of JP2023052094A5 publication Critical patent/JP2023052094A5/ja
Priority to JP2025002163A priority Critical patent/JP2025061064A/ja
Application granted granted Critical
Publication of JP7617890B2 publication Critical patent/JP7617890B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022209142A 2019-03-14 2022-12-27 タンパク質チロシンホスファターゼ阻害物質及びその使用方法 Active JP7617890B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025002163A JP2025061064A (ja) 2019-03-14 2025-01-07 タンパク質チロシンホスファターゼ阻害物質及びその使用方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962818447P 2019-03-14 2019-03-14
US62/818,447 2019-03-14
JP2021555178A JP7204005B2 (ja) 2019-03-14 2020-03-13 タンパク質チロシンホスファターゼ阻害物質及びその使用方法
PCT/US2020/022717 WO2020186199A1 (en) 2019-03-14 2020-03-13 Protein tyrosine phosphatase inhibitors and methods of use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021555178A Division JP7204005B2 (ja) 2019-03-14 2020-03-13 タンパク質チロシンホスファターゼ阻害物質及びその使用方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025002163A Division JP2025061064A (ja) 2019-03-14 2025-01-07 タンパク質チロシンホスファターゼ阻害物質及びその使用方法

Publications (3)

Publication Number Publication Date
JP2023052094A JP2023052094A (ja) 2023-04-11
JP2023052094A5 true JP2023052094A5 (https=) 2023-10-25
JP7617890B2 JP7617890B2 (ja) 2025-01-20

Family

ID=70190226

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021555178A Active JP7204005B2 (ja) 2019-03-14 2020-03-13 タンパク質チロシンホスファターゼ阻害物質及びその使用方法
JP2022209142A Active JP7617890B2 (ja) 2019-03-14 2022-12-27 タンパク質チロシンホスファターゼ阻害物質及びその使用方法
JP2025002163A Pending JP2025061064A (ja) 2019-03-14 2025-01-07 タンパク質チロシンホスファターゼ阻害物質及びその使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021555178A Active JP7204005B2 (ja) 2019-03-14 2020-03-13 タンパク質チロシンホスファターゼ阻害物質及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025002163A Pending JP2025061064A (ja) 2019-03-14 2025-01-07 タンパク質チロシンホスファターゼ阻害物質及びその使用方法

Country Status (24)

Country Link
US (1) US10851073B2 (https=)
EP (1) EP3938038A1 (https=)
JP (3) JP7204005B2 (https=)
KR (2) KR102533599B1 (https=)
CN (2) CN114025844B (https=)
AR (1) AR118374A1 (https=)
AU (2) AU2020234712B2 (https=)
BR (1) BR112021017430A2 (https=)
CA (1) CA3131894A1 (https=)
CL (2) CL2021002382A1 (https=)
CO (1) CO2021013524A2 (https=)
CR (1) CR20210516A (https=)
DO (1) DOP2021000188A (https=)
EC (1) ECSP21075909A (https=)
IL (2) IL286373B2 (https=)
MA (1) MA55301A (https=)
MX (2) MX2021010544A (https=)
MY (1) MY209419A (https=)
PE (2) PE20252767A1 (https=)
PH (1) PH12021552194A1 (https=)
SG (1) SG11202109067PA (https=)
TW (2) TWI849082B (https=)
UY (1) UY38613A (https=)
WO (1) WO2020186199A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL286373B2 (en) * 2019-03-14 2026-03-01 Calico Life Sciences Llc Protein tyrosine phosphate inhibitor compounds and uses thereof
EP4073242A4 (en) 2019-12-12 2024-01-03 Kumquat Biosciences Inc. Compositions and methods for potentiating immune activity
CA3162069A1 (en) * 2019-12-18 2021-06-24 Elliot P. Farney Protein tyrosine phosphatase inhibitors and methods of use thereof
MX2023002953A (es) * 2020-09-11 2023-06-01 Calico Life Sciences Llc Inhibidores de proteína tirosina fosfatasa y métodos para su uso.
IL305072A (en) * 2021-02-12 2023-10-01 Recovery Therapeutics Inc Compounds, compositions, and methods for modulating fgf activity
WO2022192598A1 (en) * 2021-03-11 2022-09-15 Kumquat Biosciences Inc. Heterocycles and uses thereof
EP4351558A4 (en) * 2021-06-10 2025-05-07 Ness Therapeutics, Inc. Compounds containing 5-(2-fluoro-6-hydroxyphenyl)-1,2,5-thiazolidin-3-one 1,1-dioxide as inhibitors of protein kinase phosphatase enzymes
MX2024005656A (es) * 2021-11-11 2024-08-06 Calico Life Sciences Llc Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos.
WO2023086498A1 (en) * 2021-11-11 2023-05-19 Calico Life Sciences Llc Protein tyrosine phosphatase inhibitors and methods of use thereof
WO2023150535A1 (en) * 2022-02-02 2023-08-10 Nerio Therapeutics, Inc. Protein tyrosine phosphatase inhibitors and uses thereof
WO2023150150A1 (en) * 2022-02-02 2023-08-10 Nerio Therapeutics, Inc. Protein tyrosine phosphatase inhibitors and uses thereof
PE20250780A1 (es) * 2022-02-02 2025-03-14 Nerio Therapeutics Inc Inhibidores de proteina tirosina fosfatasa y usos de estos
US20250206757A1 (en) * 2022-03-21 2025-06-26 Gasherbrum Bio, Inc. 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
JP2025513882A (ja) * 2022-04-14 2025-04-30 ネリオ セラピューティクス，インク． タンパク質チロシンホスファターゼ阻害剤およびその使用
EP4522594A4 (en) * 2022-05-13 2026-04-22 Mondego Bio Lda A Limited Liability Company By Quotas Soc Por Quotas PTPN2 INHIBITORS
CN119790052A (zh) * 2022-09-13 2025-04-08 金橘生物科技公司 苯并稠合的n-杂环及其用途
WO2024067802A1 (zh) * 2022-09-30 2024-04-04 深圳众格生物科技有限公司 蛋白酪氨酸磷酸酶抑制剂及其制备方法和医药用途
WO2024141015A1 (en) * 2022-12-30 2024-07-04 Insilico Medicine Ip Limited Protein tyrosine phosphatase inhibitors and uses thereof
PE20252789A1 (es) 2023-05-24 2025-12-22 Kumquat Biosciences Inc Compuestos heterociclicos y usos de estos
AU2024288616A1 (en) * 2023-07-11 2026-02-12 Shenzhen Zhongge Biological Technology Co., Ltd. Protein tyrosine phosphatase inhibitor, composition comprising same, and medical use thereof
KR20260040037A (ko) 2023-07-14 2026-03-23 카톨리에케 유니버시테이트 루벤 암 및 대사 질병의 치료를 위한 신규 화합물
WO2025026158A1 (zh) * 2023-07-28 2025-02-06 杭州中美华东制药有限公司 具有ptpn2抑制作用的化合物及其用途
WO2025030008A1 (en) * 2023-08-02 2025-02-06 Nerio Therapeutics, Inc. Protein tyrosine phosphatase inhibitor combinations
CN121889379A (zh) * 2023-09-15 2026-04-17 深圳众格生物科技有限公司 蛋白酪氨酸磷酸酶抑制剂及其组合物、医药用途
CN120004876B (zh) * 2023-11-16 2026-02-06 英矽智能科技(上海)有限公司 蛋白酪氨酸磷酸酶抑制剂及其应用
CN117343052B (zh) * 2023-12-04 2024-02-06 英矽智能科技(上海)有限公司 蛋白酪氨酸磷酸酶抑制剂及其应用
WO2025136841A1 (en) * 2023-12-19 2025-06-26 Merck Sharp & Dohme Llc Substituted isoquinoline derivatives and methods of use thereof
WO2025242216A1 (zh) * 2024-05-24 2025-11-27 杭州百新生物医药科技有限公司 吲哚啉类化合物及其用途
WO2026077417A1 (zh) * 2024-10-11 2026-04-16 杭州百新生物医药科技有限公司 一种用于制备ptpn1/n2抑制剂的中间体及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
CA2463615C (en) 2001-10-30 2011-07-26 Applied Research Systems Ars Holding N.V. Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
UA94921C2 (en) 2005-12-08 2011-06-25 Новартис Аг 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
UA94724C2 (en) * 2005-12-08 2011-06-10 Новартис Аг Thiadiazolidinone derivatives as antidiabetic agents
CA2647472A1 (en) 2006-03-31 2007-10-11 Novartis Ag Organic compounds
WO2008142198A2 (en) 2007-05-23 2008-11-27 Valtion Teknillinen Tutkimuskeskus A method for inhibiting or stimulating angiogenesis in an individual
AR066820A1 (es) 2007-06-04 2009-09-16 Novartis Ag Compuestos de tiadiazolidin-3 ona
WO2010008852A2 (en) 2008-06-23 2010-01-21 Taiga Biotechnologies, Inc. Methods of trea fing λλd methods of diagnosing an immunoproliferative disorder
US9217012B2 (en) 2009-04-08 2015-12-22 Indiana University Research And Technology Corporation Inhibitors of protein tyrosine phosphatases
WO2011057331A1 (en) 2009-11-11 2011-05-19 Monash University A method for treating obesity
EP2531616A4 (en) 2010-02-03 2013-07-10 Univ Monash DIAGNOSIS AND FORECAST ASSAY FOR BREAST CANCER
KR101668574B1 (ko) * 2012-11-02 2016-10-24 화이자 인코포레이티드 브루톤 티로신 키나제 억제제
WO2015127548A1 (en) 2014-02-28 2015-09-03 The Royal Institution For The Advancement Of Learning / Mcgill University Tc-ptp inhibitors as apc activators for immunotherapy
EP3154555A4 (en) 2014-06-10 2018-02-28 Monash University Method of producing leukocytes using ptpn2 inhibition for adoptive cell transfer
CN106922146B (zh) * 2014-10-02 2020-05-26 豪夫迈·罗氏有限公司 用于治疗由布鲁顿酪氨酸激酶(btk)介导的疾病的吡唑甲酰胺化合物
WO2017078499A2 (ko) 2015-11-06 2017-05-11 경북대학교 산학협력단 단백질 타이로신 탈인산화효소 억제제를 포함하는 신경염증성 질환의 예방 또는 치료용 조성물
US20180325925A1 (en) 2015-11-06 2018-11-15 Kyungpook National University Industry-Academic Cooperation Foundation Composition for prevention or treatment of neuroinflammatory disease, containing protein tyrosine phosphatase inhibitor
WO2018148378A1 (en) 2017-02-08 2018-08-16 Dana-Farber Cancer Institute, Inc. Modulating biomarkers to increase tumor immunity and improve the efficiacy of cancer immunotherapy
WO2018227248A1 (en) 2017-06-13 2018-12-20 Monash University Methods and compositions for the treatment of obesity
WO2019036815A1 (en) 2017-08-24 2019-02-28 The Royal Institution For The Advancement Of Learning/Mcgill University ENHANCEMENT OF CD8 + T LYMPHOCYTES FOR ADOPTIVE CELL THERAPY BY INHIBITING PTPN1 (PTP1B) AND PTPN2 (TC-PTP))
BR112020026086A2 (pt) * 2018-06-21 2021-03-23 Calico Life Sciences Llc inibidores da proteína tirosina fosfatase e métodos de uso destes
IL286373B2 (en) 2019-03-14 2026-03-01 Calico Life Sciences Llc Protein tyrosine phosphate inhibitor compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2023052094A5 (https=)
JP2024543976A5 (https=)
JP2024543982A5 (https=)
JP2004534774A5 (https=)
JP2007533686A (ja) 性的障害ｉｉ治療用の新規医薬組成物
IL205501A (en) Preparation of preparations for the treatment of arthritis
RU2011129856A (ru) Схема приема агониста рецептора s1p
RU2014105624A (ru) Соединения индазола, способ их применения и фармацевтическая композиция
EP1773341A1 (en) Piperazine derivatives for the treatment of female sexual disorders
CN102908347A (zh) 取代的喹啉衍生物在治疗耐药性分枝杆菌性疾病中的用途
JP2022500425A5 (https=)
JP2021515010A5 (https=)
JP2007513201A5 (https=)
RU2005116254A (ru) Производные пиридопирролизина и пиридоиндолизина
JP2019509276A5 (https=)
CA2569850A1 (en) 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer
JP2014504622A5 (https=)
JP2004525174A5 (https=)
RU2006132071A (ru) Производные антраниловой кислоты, способы их получения и применение
JP2020514315A5 (https=)
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
JP2011506501A5 (https=)
JP2017531677A5 (https=)
MY128609A (en) Ccr5 antagonists useful for treating aids.
JP2004517843A5 (https=)